{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:17:07Z","timestamp":1788797827743,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2366,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.jacc.2006.10.067","type":"journal-article","created":{"date-parts":[[2007,2,27]],"date-time":"2007-02-27T15:26:22Z","timestamp":1172589982000},"page":"1027-1034","source":"Crossref","is-referenced-by-count":98,"title":["Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina"],"prefix":"10.1016","volume":"49","author":[{"given":"Michael J.","family":"Koren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Crager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2006.10.067_bib1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jacc.2003.11.045","article-title":"Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina","volume":"43","author":"Chaitman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2006.10.067_bib3","first-page":"131","article-title":"Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem","volume":"20","author":"Cocco","year":"1992","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacc.2006.10.067_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9149(99)00190-3","article-title":"A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents","volume":"84","author":"Pepine","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jacc.2006.05.044","article-title":"Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial","volume":"48","author":"Stone","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-106-6-793","article-title":"Exercise treadmill score for predicting prognosis in coronary artery disease","volume":"106","author":"Mark","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacc.2006.10.067_bib7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.amjcard.2003.10.044","article-title":"Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR])","volume":"93","author":"Michaels","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib8","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0735-1097(02)02560-3","article-title":"Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients","volume":"40","author":"Morrison","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199909303411403","article-title":"Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina","volume":"341","author":"Allen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.10.067_bib10","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2006.10.067_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(04)16980-8","article-title":"Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial","volume":"364","author":"Poole-Wilson","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2006.10.067_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1056\/NEJM199109193251204","article-title":"Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease","volume":"325","author":"Mark","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2006.10.067_bib13","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.320.7237.741","article-title":"Incidence and types of preventable adverse events in elderly patients: population based review of medical records","volume":"320","author":"Thomas","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2006.10.067_bib14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","article-title":"Incidence and preventability of adverse drug events among older persons in the ambulatory setting","volume":"289","author":"Gurwitz","year":"2003","journal-title":"JAMA"},{"issue":"Suppl III","key":"10.1016\/j.jacc.2006.10.067_bib15","first-page":"III679","article-title":"Long-term therapy with ranolazine prevents progressive left ventricular dysfunction and remodeling in dogs with chronic heart failure (abstr)","volume":"110","author":"Sabbah","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2006.10.067_bib16","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1054\/jcaf.2002.129232","article-title":"Ranolazine, a partial fatty acid oxidation (pFOX) inhibitor, improves left ventricular function in dogs with chronic heart failure","volume":"8","author":"Sabbah","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacc.2006.10.067_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/clc.4960240604","article-title":"The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results","volume":"24","author":"Barsness","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2006.10.067_bib18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tips.2003.10.002","article-title":"Assessing predictors of drug-induced torsade de pointes","volume":"24","author":"Belardinelli","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jacc.2006.10.067_bib19","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109706031238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109706031238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T02:26:29Z","timestamp":1547000789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109706031238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0735109706031238"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2006.10.067","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}